These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25026485)

  • 1. Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006.
    Kato K; Wong LY; Chen A; Dunbar C; Webster GM; Lanphear BP; Calafat AM
    Environ Sci Technol; 2014 Aug; 48(16):9600-8. PubMed ID: 25026485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.
    Olsen GW; Butenhoff JL; Zobel LR
    Reprod Toxicol; 2009 Jun; 27(3-4):212-230. PubMed ID: 19429401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of perfluoroalkyl substances in cord serum and association with growth indicators in newborns from Beijing.
    Shi Y; Yang L; Li J; Lai J; Wang Y; Zhao Y; Wu Y
    Chemosphere; 2017 Feb; 169():396-402. PubMed ID: 27886542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal-maternal factors and perfluoroalkyl substances in cord blood.
    Lien GW; Huang CC; Wu KY; Chen MH; Lin CY; Chen CY; Hsieh WS; Chen PC
    Chemosphere; 2013 Aug; 92(7):843-50. PubMed ID: 23689097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study.
    Fisher M; Arbuckle TE; Liang CL; LeBlanc A; Gaudreau E; Foster WG; Haines D; Davis K; Fraser WD
    Environ Health; 2016 May; 15(1):59. PubMed ID: 27142700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study.
    Webster GM; Venners SA; Mattman A; Martin JW
    Environ Res; 2014 Aug; 133():338-47. PubMed ID: 25019470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study.
    Buck CO; Eliot MN; Kelsey KT; Calafat AM; Chen A; Ehrlich S; Lanphear BP; Braun JM
    Pediatr Res; 2018 Dec; 84(6):854-860. PubMed ID: 30250302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between perfluorinated compound concentrations in cord serum and birth weight using multiple regression models.
    Lee ES; Han S; Oh JE
    Reprod Toxicol; 2016 Jan; 59():53-9. PubMed ID: 26562669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort.
    Fei C; McLaughlin JK; Tarone RE; Olsen J
    Environ Health Perspect; 2007 Nov; 115(11):1677-82. PubMed ID: 18008003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort.
    Liang H; Wang Z; Miao M; Tian Y; Zhou Y; Wen S; Chen Y; Sun X; Yuan W
    Environ Health; 2020 Nov; 19(1):127. PubMed ID: 33243245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isomers of perfluorooctanesulfonate (PFOS) in cord serum and birth outcomes in China: Guangzhou Birth Cohort Study.
    Li M; Zeng XW; Qian ZM; Vaughn MG; Sauvé S; Paul G; Lin S; Lu L; Hu LW; Yang BY; Zhou Y; Qin XD; Xu SL; Bao WW; Zhang YZ; Yuan P; Wang J; Zhang C; Tian YP; Nian M; Xiao X; Fu C; Dong GH
    Environ Int; 2017 May; 102():1-8. PubMed ID: 28297681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
    Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among maternal perfluoroalkyl substance levels, fetal sex-hormone enzymatic gene polymorphisms, and fetal sex hormone levels in the Hokkaido study.
    Kobayashi S; Sata F; Ikeda-Araki A; Miyashita C; Itoh S; Goudarzi H; Iwasaki Y; Mitsui T; Moriya K; Shinohara N; Cho K; Kishi R
    Reprod Toxicol; 2021 Oct; 105():221-231. PubMed ID: 34536543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth.
    Apelberg BJ; Witter FR; Herbstman JB; Calafat AM; Halden RU; Needham LL; Goldman LR
    Environ Health Perspect; 2007 Nov; 115(11):1670-6. PubMed ID: 18008002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between maternal perfluoroalkyl substance levels, polymorphisms of receptor genes, and adverse birth outcomes in the Hokkaido birth cohort study, Japan.
    Kobayashi S; Sata F; Ikeda-Araki A; Miyashita C; Goudarzi H; Iwasaki Y; Nakajima T; Kishi R
    Reprod Toxicol; 2022 Jan; 107():112-122. PubMed ID: 34896592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.